EP2403497A4 - Compounds, compositions and use for anticancer therapy - Google Patents

Compounds, compositions and use for anticancer therapy

Info

Publication number
EP2403497A4
EP2403497A4 EP10748321.6A EP10748321A EP2403497A4 EP 2403497 A4 EP2403497 A4 EP 2403497A4 EP 10748321 A EP10748321 A EP 10748321A EP 2403497 A4 EP2403497 A4 EP 2403497A4
Authority
EP
European Patent Office
Prior art keywords
compositions
compounds
anticancer therapy
anticancer
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10748321.6A
Other languages
German (de)
French (fr)
Other versions
EP2403497A1 (en
Inventor
Ming Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP2403497A1 publication Critical patent/EP2403497A1/en
Publication of EP2403497A4 publication Critical patent/EP2403497A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
EP10748321.6A 2009-03-01 2010-03-01 Compounds, compositions and use for anticancer therapy Withdrawn EP2403497A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15650709P 2009-03-01 2009-03-01
PCT/CN2010/070813 WO2010099731A1 (en) 2009-03-01 2010-03-01 Compounds, compositions and use for anticancer therapy

Publications (2)

Publication Number Publication Date
EP2403497A1 EP2403497A1 (en) 2012-01-11
EP2403497A4 true EP2403497A4 (en) 2014-01-22

Family

ID=42709220

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10748321.6A Withdrawn EP2403497A4 (en) 2009-03-01 2010-03-01 Compounds, compositions and use for anticancer therapy

Country Status (4)

Country Link
EP (1) EP2403497A4 (en)
CN (1) CN102438620A (en)
AU (1) AU2010220755B2 (en)
WO (1) WO2010099731A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105636583B (en) 2013-09-13 2019-08-20 板井昭子 Aqueous solution preparation and its manufacturing method
KR102436172B1 (en) * 2016-03-07 2022-08-24 미토콘 파마슈티칼스, 인크. DNP and DNP prodrug treatment of neuromuscular disease, neurodegenerative disease, autoimmune disease, developmental disease, concussion, dry eye, and/or metabolic disease
CN108752477A (en) * 2018-06-19 2018-11-06 上海赛群生物科技有限公司 Application of the tNOX antibody and combinations thereof in preparing tumour cell drug
CN110115712A (en) * 2019-07-04 2019-08-13 兰州大学 Activator that is a kind of while activating oxidative phosphorylation access and inhibition glycolytic pathway and its application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132004A1 (en) * 2003-01-06 2004-07-08 Jun Nakamura Method of detecting DNA single strand breaks
US20060189680A1 (en) * 2005-01-31 2006-08-24 Bing-Hua Jiang Apigenin for chemoprevention, and chemotherapy combined with therapeutic reagents
WO2009006555A2 (en) * 2007-07-02 2009-01-08 Yu, Ming Methods, composition, targets for combinational cancer treatments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070212360A1 (en) * 2006-01-17 2007-09-13 Denko Nicholas C Modulation of mitochondrial oxygen consumption for therapeutic purposes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132004A1 (en) * 2003-01-06 2004-07-08 Jun Nakamura Method of detecting DNA single strand breaks
US20060189680A1 (en) * 2005-01-31 2006-08-24 Bing-Hua Jiang Apigenin for chemoprevention, and chemotherapy combined with therapeutic reagents
WO2009006555A2 (en) * 2007-07-02 2009-01-08 Yu, Ming Methods, composition, targets for combinational cancer treatments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2010099731A1 *

Also Published As

Publication number Publication date
AU2010220755A1 (en) 2011-10-27
EP2403497A1 (en) 2012-01-11
WO2010099731A1 (en) 2010-09-10
AU2010220755B2 (en) 2013-08-22
CN102438620A (en) 2012-05-02

Similar Documents

Publication Publication Date Title
IL242999B (en) Pyrazolopyrimidine compounds, pharmaceutical compositions comprising thereof and uses thereof
ZA201200054B (en) Therapeutic compounds and compositions
GB0909680D0 (en) Dosage form
HK1253355A1 (en) Therapeutic compositions containing macitentan
AP3250A (en) Tablets for combination therapy
IL216388A0 (en) New compounds, pharmaceutical composition and methods relating thereto
GB0808835D0 (en) Therapeutic compositions
GB0819958D0 (en) Therapeutic compositions
EP2485721A4 (en) Apogossypolone derivatives as anticancer agents
IL212375A0 (en) Naphthamides as anticancer agents
EP2544542A4 (en) Analgesic compounds, compositions, and uses thereof
EP2403497A4 (en) Compounds, compositions and use for anticancer therapy
EP2565192A4 (en) Anticancer agent
IL208001A0 (en) Improved anticancer treatments
GB0915319D0 (en) Combination medicament
IL213445A0 (en) Anticancer compounds
PL2263454T3 (en) Treatment composition
GB0916997D0 (en) Combination therapy
GB0900786D0 (en) Therapeutic compositions
EP2490704A4 (en) Therapeutic composition
GB0907973D0 (en) Combination therapy
GB201010608D0 (en) Compounds, compositions and use
GB0908537D0 (en) Compositions for treating tumours
EP2474325A4 (en) Drug composition for angiogenesis therapy
GB0814469D0 (en) Treatment for tumours

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110923

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20140107

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 45/06 20060101ALI20131219BHEP

Ipc: A61K 31/41 20060101AFI20131219BHEP

Ipc: A61K 31/498 20060101ALI20131219BHEP

Ipc: A61P 35/00 20060101ALI20131219BHEP

Ipc: A61K 31/352 20060101ALI20131219BHEP

Ipc: A61K 31/353 20060101ALI20131219BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140805